These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 13464091)

  • 1. Studies on the inhibition of fibrinolysis by lipids.
    GREIG HB; RUNDE IA
    Lancet; 1957 Sep; 273(6993):461-4. PubMed ID: 13464091
    [No Abstract]   [Full Text] [Related]  

  • 2. Wetting of fibrin plate and apparent promotion of fibrinolysis by surfactin, a new bacterial peptidelipid surfactant.
    Kakinuma A; Tamura G; Arima K
    Experientia; 1968 Nov; 24(11):1120-1. PubMed ID: 4976420
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinolysis after intravenous injection of bacterial pyrogens].
    EICHENBERGER E
    Acta Neuroveg (Wien); 1955; 11(1-4):201-6. PubMed ID: 13258198
    [No Abstract]   [Full Text] [Related]  

  • 4. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
    Zhitkova IuV; Aĭsina RB; Varfolomeev SD
    Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fish-oil constituents and plasma lipids on fibrinolysis in vitro.
    al-Awadhi AM; Dunn CD
    Br J Biomed Sci; 2000; 57(4):273-80. PubMed ID: 11204855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of lipids on fibrinolysis.
    Chopin SF; Beard EL
    Thromb Diath Haemorrh; 1973 May; 29(2):286-92. PubMed ID: 4357632
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of Fibrinolysis by Coagulation Factor XIII.
    Rijken DC; Uitte de Willige S
    Biomed Res Int; 2017; 2017():1209676. PubMed ID: 28761875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinolysis following intravenous fat infusions].
    Skála J; Kastilová B; Skála I; Janele J
    Cesk Gastroenterol Vyz; 1966 Jun; 20(4):255-8. PubMed ID: 5963471
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
    Sakata Y; Aoki N
    J Clin Invest; 1982 Mar; 69(3):536-42. PubMed ID: 7199538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs.
    Wu C; Dong N; da Cunha V; Martin-McNulty B; Tran K; Nagashima M; Wu Q; Morser J; Wang YX
    Thromb Haemost; 2003 Sep; 90(3):414-21. PubMed ID: 12958609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of endogenous fibrinolysis does not reduce local fibrin deposition, but modulates inflammation upon intestinal ischemia and reperfusion.
    Schoots IG; Levi M; van Vliet AK; Declerck PJ; Maas AM; van Gulik TM
    Thromb Haemost; 2004 Mar; 91(3):497-505. PubMed ID: 14983225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator.
    Silva MM; Thelwell C; Williams SC; Longstaff C
    J Thromb Haemost; 2012 Nov; 10(11):2354-60. PubMed ID: 22974122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of fibrinolysis in vivo by feeding cholesterol.
    KWAAN HC; MCFADZEAN AJ
    Nature; 1957 Feb; 179(4553):260. PubMed ID: 13407698
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrin breakdown products and fibrinolysis in renal disease.
    Wardle EN; Taylor G
    J Clin Pathol; 1968 Mar; 21(2):140-6. PubMed ID: 5697045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
    Kim S; Wadhwa NK; Kant KS; Pollak VE; Glas-Greenwalt P; Weiss MA; Hong CG
    Q J Med; 1988 Nov; 69(259):879-905. PubMed ID: 3078212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease.
    Adány R; Szegedi A; Ablin RJ; Muszbek L
    Thromb Haemost; 1988 Oct; 60(2):293-7. PubMed ID: 3064359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinolysis activities and factor XIII in the neonatal period. 1. Fibrinolysis activity and fibrin degradation products in the neonatal period].
    Yamada Z
    Nihon Shonika Gakkai Zasshi; 1971 Apr; 75(4):294-6. PubMed ID: 4252802
    [No Abstract]   [Full Text] [Related]  

  • 20. New model for in vivo studies of pharmacological interventions with endogenous fibrinolysis: effects of thrombin inhibitors.
    Lenfors S; Gustafsson D
    Semin Thromb Hemost; 1996; 22(4):335-42. PubMed ID: 8944418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.